Speaker(s): 

Eric Carruth, PhD, Assistant Professor, Department of Genomic Health, Research Institute, Geisinger
 
 
Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Understand the opportunities and challenges associated with a preventive, precision medicine approach to ACM using genome screening.
  • Recognize the importance of ACM genotypes and their differential impact on phenotypic features and risk profiles in a genome-first cohort.
  • Explore sub-clinical phenotypic features that may indicate future disease risk in individuals with a genotype but no appreciable clinical phenotype.
 
Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christa Martin, PhD, Eric Wright, PharmD, MPH, Adam Buchanan, MS, MPH, CGC, Candice Laubach, MBA, Jenn Nunamaker and Christian Lynch, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Dr. Carruth has nothing to disclose.  

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commercial Support for this Session

None.

Session date: 
11/25/2024 - 5:00pm to 6:00pm EST
Location: 
MS Teams
PA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation Credit

Please login or register to take this course.